Hi Mr daeff,
gsk used to report in their quarterlies that approval was pending. They seem to have given up saying that now. But as far as I am aware, all is good.
They have produced enough great data. It's crazy when one thinks about how much better it has been proved to be!
Arixtra is the best!
southern cross - biotech report, page-7
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable